Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00827762 · ClinicalTrials.gov registry record
Behavioral Effects of Kuvan in Children With Mild Phenylketonuria
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 2
- Enrollment target
NCT00827762 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 2 participants.
The verdict
NCT00827762 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether improvements in behavior occur in children with phenylketonuria (PKU) who are taking Kuvan.
Interventions
- DRUG Kuvan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00827762
The ClinicalTrials.gov registry entry for NCT00827762 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kuvan is the first listed.
NCT00827762 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00827762 about?
NCT00827762 is a clinical study titled "Behavioral Effects of Kuvan in Children With Mild Phenylketonuria". The purpose of this study is to determine whether improvements in behavior occur in children with phenylketonuria (PKU) who are taking Kuvan.
What is the current status of trial NCT00827762?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2009-01. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00827762?
The interventions under investigation include: Kuvan (DRUG).
Who is sponsoring clinical trial NCT00827762?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.